These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 36910075)
61. Frequency and Clinical Associating Factors of Valvular Heart Disease in Asymptomatic Korean Adults. Kim MS; Cho SJ; Park SJ; Cho SW; Choi SH; Kim HS; Carriere K; Kim EK; Chang SA; Lee SC; Park SW Sci Rep; 2019 Nov; 9(1):16741. PubMed ID: 31727975 [TBL] [Abstract][Full Text] [Related]
62. Atrial fibrillation, the arrhythmia of the elderly, causes and associated conditions. Levy S Anadolu Kardiyol Derg; 2002 Mar; 2(1):55-60. PubMed ID: 12101796 [TBL] [Abstract][Full Text] [Related]
63. Left-sided valvular heart disease in dialysis recipients: a single-centre observational study. Elewa M; Mitra S; Jayanti A Clin Kidney J; 2023 Jul; 16(7):1092-1101. PubMed ID: 37398684 [TBL] [Abstract][Full Text] [Related]
64. Coronary artery disease, left ventricular hypertrophy and diastolic dysfunction are associated with stroke in patients affected by persistent non-valvular atrial fibrillation: a case-control study. Palmiero P; Maiello M; Passantino A Heart Int; 2009 Jun; 4(1):e2. PubMed ID: 21977279 [TBL] [Abstract][Full Text] [Related]
65. Influence of atrial fibrillation on microRNA expression profiles in left and right atria from patients with valvular heart disease. Cooley N; Cowley MJ; Lin RC; Marasco S; Wong C; Kaye DM; Dart AM; Woodcock EA Physiol Genomics; 2012 Feb; 44(3):211-9. PubMed ID: 22147268 [TBL] [Abstract][Full Text] [Related]
66. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide in Elderly Patients With Valvular Heart Disease. Zhang B; Xu H; Zhang H; Liu Q; Ye Y; Hao J; Zhao Q; Qi X; Liu S; Zhang E; Xu Y; Gao R; Pibarot P; Clavel MA; Wu Y; J Am Coll Cardiol; 2020 Apr; 75(14):1659-1672. PubMed ID: 32273031 [TBL] [Abstract][Full Text] [Related]
68. Usefulness of platelet count to predict concomitant valvular heart disease in patients with systemic lupus erythematosus. Usuku H; Yamamoto E; Sakata K; Hirata S; Toda A; Oike F; Tabata N; Ishii M; Hanatani S; Hoshiyama T; Sueta D; Kanazawa H; Arima Y; Takashio S; Matsuzawa Y; Kawano H; Yasunaga JI; Tsujita K Int J Cardiol Heart Vasc; 2024 Aug; 53():101420. PubMed ID: 38826833 [TBL] [Abstract][Full Text] [Related]
69. Valvular heart disease in Japan: Characteristics and treatment of patients in acute care hospitals in 2019. Izumi C; Matsuyama R; Asaoka M; Iwasaki K; Takeshima T; Murphy S; Teng L; Igarashi A J Cardiol; 2023 Jul; 82(1):29-34. PubMed ID: 36963659 [TBL] [Abstract][Full Text] [Related]
70. Evaluation of the Safety and Effectiveness of Direct-Acting Oral Anticoagulants in Patients with Atrial Fibrillation and Coexisting Valvular Heart Disease. Hampton ML; Tellor KB; Armbruster AL; Theodos G; Schwarze MW Am J Cardiovasc Drugs; 2020 Dec; 20(6):611-617. PubMed ID: 32043243 [TBL] [Abstract][Full Text] [Related]
71. Incidence and patterns of valvular heart disease in a tertiary care high-volume cardiac center: a single center experience. Manjunath CN; Srinivas P; Ravindranath KS; Dhanalakshmi C Indian Heart J; 2014; 66(3):320-6. PubMed ID: 24973838 [TBL] [Abstract][Full Text] [Related]
72. Construction of Prediction Model for Atrial Fibrillation with Valvular Heart Disease Based on Machine Learning. Li Q; Lei S; Luo X; He J; Fang Y; Yang H; Liu Y; Deng CY; Wu S; Xue YM; Rao F Rev Cardiovasc Med; 2022 Jul; 23(7):247. PubMed ID: 39076905 [TBL] [Abstract][Full Text] [Related]
73. Association of Serum Uric Acid with Non-Valvular Atrial Fibrillation: A Retrospective Study in China. Yuan HJ; Jiao HC; Liu XJ; Hao H; Liu Y; Xue YT; Li Y Int J Gen Med; 2024; 17():1533-1543. PubMed ID: 38680194 [TBL] [Abstract][Full Text] [Related]
74. Clinical and echocardiographic follow-up in pregnant patients with valvular heart disease. Gümrükçüoğlu HA; Güler A; Odabaşı D; Şimşek H; Şahin M; Akdağ S; Karapınar H; Akyol A; Güneş Y; Tuncer M Turk Kardiyol Dern Ars; 2013 Jan; 41(1):31-7. PubMed ID: 23518936 [TBL] [Abstract][Full Text] [Related]
75. Impact of preoperative atrial fibrillation on mortality and cardiovascular outcomes of mechanical mitral valve replacement for rheumatic mitral valve disease. Wang B; Xu ZY; Han L; Zhang GX; Lu FL; Song ZG Eur J Cardiothorac Surg; 2013 Mar; 43(3):513-9. PubMed ID: 22621873 [TBL] [Abstract][Full Text] [Related]
76. LDL-C/HDL-C is associated with ischaemic stroke in patients with non-valvular atrial fibrillation: a case-control study. Zhang XX; Wei M; Shang LX; Lu YM; Zhang L; Li YD; Zhang JH; Xing Q; Tu-Erhong ZK; Tang BP; Zhou XH Lipids Health Dis; 2020 Oct; 19(1):217. PubMed ID: 33028331 [TBL] [Abstract][Full Text] [Related]
77. Wearable device-measured moderate to vigorous physical activity and risk of degenerative aortic valve stenosis. Li Z; Cheng S; Guo B; Ding L; Liang Y; Shen Y; Li J; Hu Y; Long T; Guo X; Ge J; Gao R; Pibarot P; Zhang B; Xu H; Clavel MA; Wu Y Eur Heart J; 2024 Jul; ():. PubMed ID: 38953786 [TBL] [Abstract][Full Text] [Related]
78. Impact of selective serotonin reuptake inhibitor therapy on heart valves in patients exposed to benfluorex: a multicentre study. Maréchaux S; Jeu A; Jobic Y; Ederhy S; Donal E; Réant P; Abouth S; Arnasteen E; Boulanger J; Ennezat PV; Garban T; Szymanski C; Tribouilloy C Arch Cardiovasc Dis; 2013; 106(6-7):349-56. PubMed ID: 23876809 [TBL] [Abstract][Full Text] [Related]